Wed, 20 Aug 2025

Shabbir Safdar, Executive Director of the Partnership for Safe Medicines, discusses the dangers of counterfeit medicines, the importance of supply chain security for American patients, how the reimbursement practices of pharmacy benefit managers (PBMs) and insurance companies impact whether or not consumers end up with counterfeits, and the importance of innovation and intellectual property policy in ensuring Americans continues to have access to new life-saving medicines.